Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/EJE-08-0050
European Journal of Endocrinology, Vol 159, Issue 1, 7-13
Copyright © 2008 by European Society of Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
EJE-08-0050v1
159/1/7    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Tanriverdi, F.
Right arrow Articles by Kelestimur, F.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanriverdi, F.
Right arrow Articles by Kelestimur, F.

CLINICAL STUDIES

Antipituitary antibodies after traumatic brain injury: is head trauma-induced pituitary dysfunction associated with autoimmunity?

Fatih Tanriverdi*, Annamaria De Bellis1,*, Antonio Bizzarro2, Antonio Agostino Sinisi1, Giuseppe Bellastella1, Elena Pane1, Antonio Bellastella1, Kursad Unluhizarci, Ahmet Selcuklu3, Felipe F Casanueva4 and Fahrettin Kelestimur

Department of Endocrinology, Erciyes University Medical School, 38039 Kayseri, Turkey1 Chair of Endocrinology and 2 Chair of Immunology, Second University of Naples, Via S. Pansini, 5, 80131 Naples, Italy3 Department of Neurosurgery,, Erciyes University Medical School, Kayseri, Turkey and 4 Department of Medicine School of Medicine and Complejo Hospitalario Universitario de Santiago,, Santiago de Compostela University, Santiago de Compostela, Spain

(Correspondence should be addressed to F Kelestimur; Email: fktimur{at}erciyes.edu.tr) (fktimur2001{at}yahoo.co.uk)

* F Tanriverdi and A De Bellis contributed equally to this work

Objective: Traumatic brain injury (TBI) is a devastating public health problem that may result in hypopituitarism. However, the mechanisms responsible for hypothalamic–pituitary dysfunction due to TBI are still unclear. Although the antibodies against neurons have been demonstrated in injured animal studies, investigations regarding the occurrence of antipituitary antibodies (APAs) in patients with TBI are lacking in the literature. In order to investigate whether autoimmune mechanisms could play a role in the pituitary dysfunction after TBI, we have planned this study aimed at investigating the presence of APA at the third year of TBI and association between the TBI-induced hypopituitarism and APA.

Patients and design: Twenty-nine (25 males and 4 females; age 36.5±2.3 years) patients who had completed a 3-year follow-up after TBI were included in the present study. APA and pituitary function were evaluated in all the patients 3 years after TBI; moreover, APAs were tested also in sera of 60 age-/sex-matched normal controls. The APAs were investigated by an indirect immunofluorescence method.

Results: APAs were detected in 13 out of the 29 TBI patients (44.8%), but in none of the normal controls. Pituitary dysfunction development ratio was significantly higher in APA-positive patients (46.2%) when compared with APA-negative ones (12.5%; P=0.04). There was a significant association between APA positivity and hypopituitarism due to TBI (odds ratio: 2.25, 95% confidence intervals 1.1–4.6). Moreover, there was a significant positive correlation (r=0.74, P=0.004) between APA titer ratio and peak GH response to GHRH+GH related peptide (GHRP)-6 test, suggesting that high APA titers were associated with low GH response to GHRH+GHRP-6 test.

Conclusions: This study shows for the first time the presence of the APA in TBI patients 3 years after head trauma. Moreover, present investigation indicates preliminary evidence that APA may be associated with the development of TBI-induced pituitary dysfunction, thus suggesting that autoimmunity may contribute in the development of TBI-induced hypopituitarism. The presence of the association between APA and TBI-induced hypopituitarism may provide a new point of view in this field and promote further clinical and experimental studies.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 European Society of Endocrinology.